Affiliation:
1. The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Ein Kerem, P.O. Box 12065, Jerusalem 9112102, Israel
Abstract
This review focuses on nanovesicular carriers for enhanced delivery of molecules into and across the skin, from their design to recent emerging technologies. During the last four decades, several approaches have been used aiming to design new nanovesicles, some of them by altering the properties of the classic phospholipid vesicle, the liposome. Phospholipid nanovesicular systems, including the phospholipid soft vesicles as well as the non-phospholipid vesicular carries, are reviewed. The altered nanovesicles have served in the manufacture of various cosmetic products and have been investigated and used for the treatment of a wide variety of skin conditions. The evolution and recent advances of these nanovesicular technologies are highlighted in this review.
Reference76 articles.
1. Touitou, E., and Natsheh, H. (2021). Topical Administration of Drugs Incorporated in Carriers Containing Phospholipid Soft Vesicles for the Treatment of Skin Medical Conditions. Pharmaceutics, 13.
2. Natsheh, H., and Touitou, E. (2020). Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties. Molecules, 25.
3. Sahin, N.O. (2007). Nanomaterials and Nanosystems for Biomedical Applications, Springer.
4. Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies;Shumilov;Int. J. Pharm.,2010
5. Transdermal drug delivery of insulin with ultradeformable carriers;Cevc;Clin. Pharmacokinet.,2003
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献